◆Jinain Pharmaceutical = Recorded an evaluation loss on derivative financial liabilities worth 5.4 billion KRW
◆Gwanglim = Recorded an evaluation loss on derivative liabilities worth 35.3 billion KRW
◆Sangji Kailum = CEO Choi Ki-bo's term expired... Kim Young-shin appointed as new CEO
Hot Picks Today
!["Not Everyone Can Afford This: Inside the World of the True Top 0.1% [Luxury World]"](https://cwcontent.asiae.co.kr/asiaresize/93/2026051507261063923_1778797570.png)
"Not Everyone Can Afford This: Inside the World of the True Top 0.1% [Luxury World]"
- "Plunged During the War, Now Surging Again"... The Real Reason Behind the 6% One-Day Silver Market Rally [Weekend Money]
- While Everyone Focused on Samsung and Nix, This Company Soared 50%... Hit Record Highs for 4 Days [Weekend Money]
- Incoming Fed Chairman Kevin Walsh to Sell $2.52 Million Worth of Coupang Shares
- "Target Price Set at 970,000 Won"... Top Investors Already Watching, Only an 'Uptrend' Remains [Weekend Money]
◆Samkang M&T = Signed a contract with the Public Procurement Service to build and supply two 3,000-ton patrol vessels worth 138.9 billion KRW
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
